Clinical and translational research
General information of the group
- Identification of new lipidic compounds and molecular mechanisms for the development of medicines and nutraceuticals against pathologies of the metabolic syndrome
- New therapeutic strategies against opposition to antitumoral drugs in hematological neoplasia, gastric and intestinal stromal tumors (GIST) and soft part sarcomas.
- Analysis of the clinic evolution and identification of molecular prediction bookmarks in hematological neoplasia, GIST and soft part sarcomas